Abiopharma

🔍 Zhang Nangeng (Executive)

Company: Canaan Inc. (CAN)

Report Date: 2026-06-17

Detailed Transactions and Holdings:

• Acquired 3,750,000 shares of American Depositary Shares (Derivative)
  Date: 2026-06-17 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,051,635.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Acquired 3,750,000 shares of American Depositary Shares (Derivative)
  Date: 2026-06-18 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,301,635.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each American Depositary Share is convertible at any time, at the holder's election, into 15 Class A ordinary shares of the issuer. The American Depositary Shares have no expiration date.